Annual report pursuant to Section 13 and 15(d)

Intangible assets, net (Tables)

v3.23.2
Intangible assets, net (Tables)
12 Months Ended
May 31, 2023
Intangible Assets, net  
Schedule of intangible assets

​

​

​

​

​

​

​

​

(in thousands)

    

May 31, 2023

    

May 31, 2022

Leronlimab (PRO 140) patent

​

$

3,500

​

$

3,500

Website development costs

​

 

20

​

 

20

Gross carrying value

​

​

3,520

​

​

3,520

Accumulated amortization, net of impairment

​

 

(3,520)

​

 

(3,388)

Total intangible assets, net

​

$

—

​

$

132